European Archives - Page 529 of 1163 - European Medical Journal

Getting to grips with customer experience

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with an interview with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD.

A Self-Resolving Flare of Psoriasis after COVID-19 Vaccination

A 63-year-old female with history of psoriasis, degenerative disc disease, and osteoarthritis of the hands and knees presented with…

A Study in Urology

Leslie Moffat discusses how males with family members who have had breast cancer could be at a higher risk of getting prostate cancer.

Access to medicine in Latin America

Track the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.

Novel targets for therapy in TD β-Thalassaemia

The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…

Pharma in South Africa, access, pricing and reimbursement

In this episode, GOLD is joined by two international experts in market access, talking about pricing, reimbursement and more in South Africa and Europe.

Management of Atopic Dermatitis in Infants: Focus on Pimecrolimus

The management of infants affected by atopic dermatitis is still a challenge. The webinar will cover the following topics: Atopic…

EMJ Interventional Cardiology 10 [Supplement 1]

EMJ presents the new issue of Interventional Cardiology eJournal (issue 10 supplement 1). Click now to find out more

Contemporary Techniques to Treat Coronary Calcification

Calcific lesions, if not adequately pre-dilated, can prevent the successful expansion of a stent during percutaneous coronary intervention…

A Retrospective Database Cohort Study Evaluating the Association Between Immune Suppressive Therapy and the Development of Cancer in Patients with Atopic Dermatitis Within UK Primary Care

Atopic dermatitis (AD) is the most common inflammatory skin condition, affecting 11–20% of children and 5–10% of adults…